Vital KSK Holdings, Inc.

3151

JP3778280002

Pharmaceuticals

Delayed Japan Exchange Other stock markets 12:08:31 2024-07-18 am EDT			5-day change	1st Jan Change
1,344 ^JPY	-0.44%		+2.67%	+28.74%

Jul. 01	Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.	CI
May. 15	Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	MT

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on June 17, 2021.

January 04, 2022 at 01:00 am EST

From October 1, 2021 to December 31, 2021, the company has repurchased 834,400 shares, representing 1.54% for ¥651.69 million. With this, the company has completed the repurchase of 1,754,900 shares, representing 3.2% for ¥1,364.61 million under the buyback announced on June 17, 2021.

Latest news about Vital KSK Holdings, Inc.

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.	Jun. 30	CI
Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	May. 15	MT
Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	May. 14	MT
Vital KSK Board OKs Up to 3 Billion Yen Share Buyback	May. 14	MT
Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.	May. 13	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	May. 12	CI
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	Feb. 07	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	Nov. 07	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million.	Nov. 07	CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023	Nov. 06	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 06	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.	Nov. 06	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	Nov. 05	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-09-24	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million.	23-09-21	CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-03	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-07-03	CI
Vital KSK Announces Voting Results	23-06-30	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI

Chart Vital KSK Holdings, Inc.

Duration

Period

More charts

Company Profile

VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.

Sector

Pharmaceuticals

Calendar

2024-08-04 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
VITAL KSK HOLDINGS, INC.	+28.74%	422M
MCKESSON CORPORATION	+25.72%	75.74B
CARDINAL HEALTH, INC.	-4.79%	23.24B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+17.81%	8.76B
HUADONG MEDICINE CO., LTD	-31.67%	6.69B
H. LUNDBECK A/S	+20.57%	5.58B
GALENICA AG	+4.12%	4.22B
EBOS GROUP LIMITED	-3.94%	3.99B
MEDIPAL HOLDINGS CORPORATION	+14.75%	3.39B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+10.59%	3.23B

Pharmaceuticals Wholesale

Vital KSK Holdings, Inc.

Equities

3151

JP3778280002

Pharmaceuticals

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on June 17, 2021.

Latest news about Vital KSK Holdings, Inc.

Chart Vital KSK Holdings, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Pharmaceuticals Wholesale